Documentos relacionados

1. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
2. Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG/ISCL survey.
3. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.
4. The Clinical Spectrum of Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder: An Updated Systematic Literature Review and Case Series.
5. Decrease of 5-hydroxymethylcytosine in primary cutaneous CD4⁺ small/medium sized pleomorphic T-cell lymphoproliferative disorder.
6. Mycosis Fungoides and Granulomatous Slack Skin: A Single Entity With Distinct Clinical Phenotypes.
7. Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma.
8. Clinical, histopathological and prognostic features of primary cutaneous acral CD8⁺ T-cell lymphoma and other dermal CD8⁺ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop.
9. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4⁺ small or medium T-cell lymphoproliferative disorder.
10. Better understanding about the severity of disease in cutaneous T-cell lymphoma from studying immune checkpoint receptors.